Navegar por autor "Ferreiro Iglesias, Rocio"

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)

2015- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio; [et al.]

Acute gastric volvulus: A surgical emergency

2011- Lesquereux Martínez, Lucía; Ferreiro Iglesias, Rocio; Macías García, Fernando; Beiras Torrado, Alejandro; Martínez Castro, Jorge Juan; [et al.]

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

2019- Bastida, G.; Marin-Jimenez, I.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model

2015- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio; Uribarri González, Laura [et al.]

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

2012- Molina Perez, Esther; Fernandez Castroagudin, Javier; Domínguez Muñoz, Juan Enrique; Lariño Noia, José; Álvarez del Castillo, Matilde; [et al.]

Correlation between adalimumab serum levels and remission after the induction phase in Crohn's Disease patients

2015- Barreiro de Acosta, Manuel; Ferreiro Iglesias, Rocio

COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)

2020- Marin-Jimenez, I.; Zabana, Y.; Rodriguez-Lago, I.; Marin, L.; Barreiro de Acosta, Manuel; [et al.]

Differences in bacteroidal genotypes between newly diagnosed ulcerative colitis patients and healthy controls

2019- Bastón Rey, Iria; Sueiro, R.; CALVIÑO SUAREZ, CRISTINA; DE LA IGLESIA GARCIA, DANIEL; FERREIRO IGLESIAS, ROCIO; [et al.]

Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU

2019- Rodriguez-Lago, I.; Castro-Poceiro, J.; Fernandez-Clotet, A.; Mesonero, F.; Lopez-Sanroman, A.; [et al.]

Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response?

2011- Seijo Rios, Susana; Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio [et al.]

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

2019- Ferreiro Iglesias, Rocio; Jardi Cuadrado, Andrea; Quiroga Castiñeira, Adriano; Bastón Rey, Iria; Gonzalez, J.; [et al.]

Female gender increases the risk of anxiety and depression in patients with inflammatory bowel disease under anti-TNF alpha therapy

2019- Ferreiro Iglesias, Rocio; CALVIÑO SUAREZ, CRISTINA; Bastón Rey, Iria; Domínguez Muñoz, Juan Enrique; Barreiro de Acosta, Manuel [et al.]

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

2019- Chaparro, M.; Aterido, A.; Guerra, I.; Iborra, M.; Cabriada, J. L.; [et al.]

Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

2019- Marin-Jimenez, I.; Bastida, G.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]

Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study

2020- Marin-Jimenez, I.; Bastida, G.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

2014- Ferreiro Iglesias, Rocio

Infliximab serum levels do not predict remission after the induction phase in Crohn's Disease patients

2015- Barreiro de Acosta, Manuel; Ferreiro Iglesias, Rocio

Influence of alexithymia on the clinical course ofInflammatory Bowel Disease (IBD)

2015- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio

Influence of anaemia on health related quality of life in inflammatory bowel disease patients

2012- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Iglesias Rey, Marta; Ferreiro Iglesias, Rocio [et al.]

Influence of anxiety and depression in the clinical course of inflammatory bowel disease patients

2014- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Iglesias Rey, Marta; Ferreiro Iglesias, Rocio [et al.]

Repositorio digital RUNA

Navegar por autor "Ferreiro Iglesias, Rocio"

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC) ﻿

Acute gastric volvulus: A surgical emergency ﻿

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study) ﻿

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model ﻿

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy ﻿

Correlation between adalimumab serum levels and remission after the induction phase in Crohn's Disease patients ﻿

COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020) ﻿

Differences in bacteroidal genotypes between newly diagnosed ulcerative colitis patients and healthy controls ﻿

Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU ﻿

Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response? ﻿

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week ﻿

Female gender increases the risk of anxiety and depression in patients with inflammatory bowel disease under anti-TNF alpha therapy ﻿

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease ﻿

Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study ﻿

Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study ﻿

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3) ﻿

Infliximab serum levels do not predict remission after the induction phase in Crohn's Disease patients ﻿

Influence of alexithymia on the clinical course ofInflammatory Bowel Disease (IBD) ﻿

Influence of anaemia on health related quality of life in inflammatory bowel disease patients ﻿

Influence of anxiety and depression in the clinical course of inflammatory bowel disease patients ﻿

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)

Acute gastric volvulus: A surgical emergency

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model

Baseline creatinine and hemodynamic response predicts reversal hepatorenal syndrome type 1 with terlipressin and albumin therapy

Correlation between adalimumab serum levels and remission after the induction phase in Crohn's Disease patients

COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)

Differences in bacteroidal genotypes between newly diagnosed ulcerative colitis patients and healthy controls

Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU

Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response?

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

Female gender increases the risk of anxiety and depression in patients with inflammatory bowel disease under anti-TNF alpha therapy

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

Impact of comorbidities on anti-TNF alpha response and relapse in patients with inflammatory bowel disease: the VERNE study

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

Infliximab serum levels do not predict remission after the induction phase in Crohn's Disease patients

Influence of alexithymia on the clinical course ofInflammatory Bowel Disease (IBD)

Influence of anaemia on health related quality of life in inflammatory bowel disease patients

Influence of anxiety and depression in the clinical course of inflammatory bowel disease patients